Key result
Omega-3 PUFA supplementation attenuates chemotherapy-induced cardiotoxic gene expression and alters cardiac mitochondrial lipids.
Why the study?
It is unknown whether dietary supplementation with long-chain omega-3 polyunsaturated fatty acids can protect against chemotherapy-induced cardiotoxicity.
Does dietary LC n-3 PUFA supplementation attenuate chemotherapy-induced markers of cardiotoxicity in an ovariectomized mouse model?
Does dietary LC n-3 PUFA supplementation attenuate chemotherapy-induced markers of cardiotoxicity in an ovariectomized mouse model?
Dietary LC n-3 PUFA supplementation alters mitochondrial lipid mediators and attenuates molecular markers of chemotherapy-induced cardiotoxicity in a preclinical mouse model.
Supports hypothesis of LC n-3 PUFA cardioprotection in mice; leaves open translation to human chemotherapy patients.
Many commonly used chemotherapies induce mitochondrial dysfunction in cardiac muscle, which leads to cardiotoxicity and heart failure later in life. Dietary long-chain omega-3 polyunsaturated fatty acids (LC n-3 PUFA) have demonstrated cardioprotective function in non-chemotherapy models of heart failure, potentially through the formation of LC n-3 PUFA-derived bioactive lipid metabolites. However, it is unknown whether dietary supplementation with LC n-3 PUFA can protect against chemotherapy-induced cardiotoxicity. To test this, 36 female ovariectomized C57BL/6J mice were randomized in a two-by-two factorial design to either a low (0 g/kg EPA + DHA) or high (12.2 g/kg EPA + DHA) LC n-3 PUFA diet, and received either two vehicle or two chemotherapy (9 mg/kg anthracycline + 90 mg/kg cyclophosphamide) tail vein injections separated by two weeks. Body weight and food intake were measured as well as heart gene expression and fatty acid composition. Heart mitochondria were isolated using differential centrifugation. Mitochondrial isolate oxylipin and N-acylethanolamide levels were measured by mass spectrometry after alkaline hydrolysis. LC n-3 PUFA supplementation attenuated some chemotherapy-induced differences (Myh7, Col3a1) in heart gene expression, and significantly altered various lipid species in cardiac mitochondrial preparations including several epoxy fatty acids [17(18)-EpETE] and N-acylethanolamines (arachidonoylethanolamine, AEA), suggesting a possible functional link between heart lipids and cardiotoxicity.
No takes yet. Share an insight, caveat, or question.
Angelotti et al. (2022) studied Chemotherapy-induced cardiotoxicity (n=36). Dietary long-chain omega-3 polyunsaturated fatty acids (LC n-3 PUFA) vs. Low LC n-3 PUFA diet (0 g/kg EPA + DHA) was evaluated on Heart gene expression (Myh7, Col3a1) and cardiac mitochondrial lipid species. Dietary long-chain omega-3 PUFA supplementation attenuated chemotherapy-induced differences in heart gene expression (Myh7, Col3a1) and significantly altered lipid species in cardiac mitochondria.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: